Literature DB >> 11522019

Platelets and phospholipids in tissue factor-initiated thrombin generation.

S Butenas1, R F Branda, C van't Veer, K M Cawthern, K G Mann.   

Abstract

The influence of platelets on tissue factor (TF)-initiated thrombin generation in a reconstituted model of blood coagulation and in whole blood was evaluated. No thrombin generation was observed over 15 min in the reconstituted model when either TF or platelets and phospholipids were omitted. At 25 pM TF, the rates of thrombin generation were platelet and PCPS concentration-dependent and achieved maximum (1.0 nM/s) in the physiological range of platelet concentration. Similar rates were achieved in the absence of platelets when 1-2 microM phospholipid was used. However, the maximum rates of thrombin generation (5.2-6.0 nM/s) and the shortest initiation phase (1 min) were attained between 25 and 100 microM phospholipid. In the reconstituted model, an increase in platelet concentration from 0.125 x 10(8)/ml to 0.5 x 10(8)/ml decreased the duration of the initiation phase (in the absence of phospholipids) from 4.3 min to 2 min. Further increases in platelet concentration did not affect this phase. Sequential whole blood studies were conducted in blood of a chemotherapy patient who developed reduced platelet counts. The TF (12.5 pM) initiated clotting of patient's blood was accelerated from approximately 10 min to 5 min when the platelet concentration increased from 0.05 x 10(8)/ml to 0.11 x 10(8)/ml. Clotting times were essentially unchanged for platelet concentrations exceeding 0.5 x 10(8)/ml (range 0.5-3.1 x 10(8)/ml). Similarly, clotting of whole blood obtained from healthy volunteers was not affected by the platelet count, which varied from 1.5 x 10(8)/ml to 3.1 x 10(8)/ml (4.0+/-0.5 min). The data obtained in both models are consistent with in vivo observations that clinical bleeding is most likely to occur at platelet counts <0.1 x 10(8)/ml.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522019

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  15 in total

1.  Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A.

Authors:  J H Foley; M E Nesheim; G E Rivard; K E Brummel-Ziedins
Journal:  Haemophilia       Date:  2011-09-20       Impact factor: 4.287

2.  Spatial propagation and localization of blood coagulation are regulated by intrinsic and protein C pathways, respectively.

Authors:  Mikhail A Panteleev; Mikhail V Ovanesov; Dmitrii A Kireev; Aleksei M Shibeko; Elena I Sinauridze; Natalya M Ananyeva; Andrey A Butylin; Evgueni L Saenko; Fazoil I Ataullakhanov
Journal:  Biophys J       Date:  2005-12-02       Impact factor: 4.033

3.  Thrombin generation and bleeding in haemophilia A.

Authors:  K E Brummel-Ziedins; M F Whelihan; M Gissel; K G Mann; G E Rivard
Journal:  Haemophilia       Date:  2009-06-26       Impact factor: 4.287

Review 4.  Thrombin generation in hemorrhage control and vascular occlusion.

Authors:  Kenneth G Mann
Journal:  Circulation       Date:  2011-07-12       Impact factor: 29.690

5.  Anticoagulation by factor Xa inhibitors.

Authors:  T Orfeo; S Butenas; K E Brummel-Ziedins; M Gissel; K G Mann
Journal:  J Thromb Haemost       Date:  2010-05-21       Impact factor: 5.824

6.  Spatial distribution of factor Xa, thrombin, and fibrin(ogen) on thrombi at venous shear.

Authors:  Michelle A Berny; Imke C A Munnix; Jocelyn M Auger; Saskia E M Schols; Judith M E M Cosemans; Peter Panizzi; Paul E Bock; Steve P Watson; Owen J T McCarty; Johan W M Heemskerk
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

7.  Whole blood thrombin generation is distinct from plasma thrombin generation in healthy volunteers and after severe injury.

Authors:  Julia R Coleman; Ernest E Moore; Jason M Samuels; Joshua J Ryon; Jesse T Nelson; Alexander Olson; Sandi Caus; Matthew G Bartley; Navin G Vigneshwar; Mitchell J Cohen; Anirban Banerjee; Christopher C Silliman; Saulius Butenas
Journal:  Surgery       Date:  2019-09-13       Impact factor: 3.982

8.  Continuous thrombin generation in whole blood: New applications for assessing activators and inhibitors of coagulation.

Authors:  Shannon M Prior; Kenneth G Mann; Kalev Freeman; Saulius Butenas
Journal:  Anal Biochem       Date:  2018-05-07       Impact factor: 3.365

Review 9.  An evolutionary perspective of animal microRNAs and their targets.

Authors:  Noam Shomron; David Golan; Eran Hornstein
Journal:  J Biomed Biotechnol       Date:  2009-09-14

10.  From principle to practice: bridging the gap in patient profiling.

Authors:  Jonathan H Foley; Thomas Orfeo; Anetta Undas; Kelley C McLean; Ira M Bernstein; Georges-Etienne Rivard; Kenneth G Mann; Stephen J Everse; Kathleen E Brummel-Ziedins
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.